Initially, PCa is reliant on androgens and AR signaling for tumor growth and progression and is characterized by a rising prostate-specific antigen (PSA) level in humans, a marker not typically expressed in dog PCa [33,34]. The gene discussed is KLK3; the disease is posterior cortical atrophy.